Page last updated: 2024-10-30

mesalamine and Hyperhomocysteinemia

mesalamine has been researched along with Hyperhomocysteinemia in 1 studies

Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.

Hyperhomocysteinemia: Condition in which the plasma levels of homocysteine and related metabolites are elevated (

Research Excerpts

ExcerptRelevanceReference
"The association between Crohn's disease, hyperhomocysteinemia and large-artery stroke of the young has rarely been reported."1.32Large-artery stroke in a young patient with Crohn's disease. Role of vitamin B6 deficiency-induced hyperhomocysteinemia. ( Berruyer, M; Derex, L; Nighoghossian, N; Philippeau, F; Salzmann, M; Trouillas, P; Younes-Mhenni, S, 2004)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Younes-Mhenni, S1
Derex, L1
Berruyer, M1
Nighoghossian, N1
Philippeau, F1
Salzmann, M1
Trouillas, P1

Other Studies

1 other study available for mesalamine and Hyperhomocysteinemia

ArticleYear
Large-artery stroke in a young patient with Crohn's disease. Role of vitamin B6 deficiency-induced hyperhomocysteinemia.
    Journal of the neurological sciences, 2004, Jun-15, Volume: 221, Issue:1-2

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Cerebral Arterial Diseases; Crohn Disease; Female; H

2004